DOI QR코드

DOI QR Code

Treatment Response Evaluation by Computed Tomography Pulmonary Vasculature Analysis in Patients With Chronic Thromboembolic Pulmonary Hypertension

  • Yu-Sen Huang (Department of Medical Imaging, National Taiwan University Hospital, National Taiwan University College of Medicine) ;
  • Zheng-Wei Chen (Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine) ;
  • Wen-Jeng Lee (Department of Medical Imaging, National Taiwan University Hospital, National Taiwan University College of Medicine) ;
  • Cho-Kai Wu (Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine) ;
  • Ping-Hung Kuo (Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine) ;
  • Hsao-Hsun Hsu (Department of Surgery, National Taiwan University Hospital, National Taiwan University College of Medicine) ;
  • Shu-Yu Tang (Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine) ;
  • Cheng-Hsuan Tsai (Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine) ;
  • Mao-Yuan Su (Department of Medical Imaging, National Taiwan University Hospital, National Taiwan University College of Medicine) ;
  • Chi-Lun Ko (Departments of Nuclear Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine) ;
  • Juey-Jen Hwang (Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine) ;
  • Yen-Hung Lin (Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine) ;
  • Yeun-Chung Chang (Department of Medical Imaging, National Taiwan University Hospital, National Taiwan University College of Medicine)
  • Received : 2022.09.09
  • Accepted : 2023.01.28
  • Published : 2023.04.01

Abstract

Objective: To quantitatively assess the pulmonary vasculature using non-contrast computed tomography (CT) in patients with chronic thromboembolic pulmonary hypertension (CTEPH) pre- and post-treatment and correlate CT-based parameters with right heart catheterization (RHC) hemodynamic and clinical parameters. Materials and Methods: A total of 30 patients with CTEPH (mean age, 57.9 years; 53% female) who received multimodal treatment, including riociguat for ≥ 16 weeks with or without balloon pulmonary angioplasty and underwent both non-contrast CT for pulmonary vasculature analysis and RHC pre- and post-treatment were included. The radiographic analysis included subpleural perfusion parameters, including blood volume in small vessels with a cross-sectional area ≤ 5 mm2 (BV5) and total blood vessel volume (TBV) in the lungs. The RHC parameters included mean pulmonary artery pressure (mPAP), pulmonary vascular resistance (PVR), and cardiac index (CI). Clinical parameters included the World Health Organization (WHO) functional class and 6-minute walking distance (6MWD). Results: The number, area, and density of the subpleural small vessels increased after treatment by 35.7% (P < 0.001), 13.3% (P = 0.028), and 39.3% (P < 0.001), respectively. The blood volume shifted from larger to smaller vessels, as indicated by an 11.3% increase in the BV5/TBV ratio (P = 0.042). The BV5/TBV ratio was negatively correlated with PVR (r = -0.26; P = 0.035) and positively correlated with CI (r = 0.33; P = 0.009). The percent change across treatment in the BV5/TBV ratio correlated with the percent change in mPAP (r = -0.56; P = 0.001), PVR (r = -0.64; P < 0.001), and CI (r = 0.28; P = 0.049). Furthermore, the BV5/TBV ratio was inversely associated with the WHO functional classes I-IV (P = 0.004) and positively associated with 6MWD (P = 0.013). Conclusion: Non-contrast CT measures could quantitatively assess changes in the pulmonary vasculature in response to treatment and were correlated with hemodynamic and clinical parameters.

Keywords

Acknowledgement

We would like to express our thanks to the staff of the Core Lab at the Department of Medical Research, National Taiwan University Hospital, for their technical support. We would like to express our gratitude to the National Taiwan University Hospital-Statistical Consulting Unit (NTUH-SCU) for statistical consultation and analyses.

References

  1. Dartevelle P, Fadel E, Mussot S, Chapelier A, Herve P, de Perrot M, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004;23:637-648
  2. Pepke-Zaba J, Delcroix M, Lang I, Mayer E, Jansa P, Ambroz D, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation 2011;124:1973-1981
  3. Chen ZW, Wu CK, Kuo PH, Hsu HH, Tsai CH, Pan CT, et al. Efficacy and safety of balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. J Formos Med Assoc 2021;120:947-955
  4. Jenkins D, Madani M, Fadel E, D'Armini AM, Mayer E. Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension. Eur Respir Rev 2017;26:160111
  5. Kwon W, Yang JH, Park TK, Chang SA, Jung DS, Cho YS, et al. Impact of balloon pulmonary angioplasty on hemodynamics and clinical outcomes in patients with chronic thromboembolic pulmonary hypertension: the initial Korean experience. J Korean Med Sci 2018;33:e24
  6. Yamasaki Y, Abe K, Kamitani T, Hosokawa K, Kawakubo M, Sagiyama K, et al. Balloon pulmonary angioplasty improves right atrial reservoir and conduit functions in chronic thromboembolic pulmonary hypertension. Eur Heart J Cardiovasc Imaging 2020;21:855-862
  7. Ghofrani HA, D'Armini AM, Grimminger F, Hoeper MM, Jansa P, Kim NH, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med 2013;369:319-329
  8. Simonneau G, D'Armini AM, Ghofrani HA, Grimminger F, Hoeper MM, Jansa P, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2). Eur Respir J 2015;45:1293-1302
  9. Papamatheakis DG, Poch DS, Fernandes TM, Kerr KM, Kim NH, Fedullo PF. Chronic thromboembolic pulmonary hypertension: JACC Focus Seminar. J Am Coll Cardiol 2020;76:2155-2169
  10. Hoeper MM, Lee SH, Voswinckel R, Palazzini M, Jais X, Marinelli A, et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol 2006;48:2546-2552
  11. Rear R, Bell RM, Hausenloy DJ. Contrast-induced nephropathy following angiography and cardiac interventions. Heart 2016;102:638-648
  12. Matsuoka S, Washko GR, Yamashiro T, Estepar RS, Diaz A, Silverman EK, et al. Pulmonary hypertension and computed tomography measurement of small pulmonary vessels in severe emphysema. Am J Respir Crit Care Med 2010;181:218-225
  13. Zhai Z, Staring M, Hernandez Giron I, Veldkamp WJH, Kroft LJ, Ninaber MK, et al. Automatic quantitative analysis of pulmonary vascular morphology in CT images. Med Phys 2019;46:3985-3997
  14. Jenkins D, Mayer E, Screaton N, Madani M. State-of-the-art chronic thromboembolic pulmonary hypertension diagnosis and management. Eur Respir Rev 2012;21:32-39
  15. Coulden R. State-of-the-art imaging techniques in chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 2006;3:577-583
  16. Rahaghi FN, Ross JC, Agarwal M, Gonzalez G, Come CE, Diaz AA, et al. Pulmonary vascular morphology as an imaging biomarker in chronic thromboembolic pulmonary hypertension. Pulm Circ 2016;6:70-81
  17. Grosse A, Grosse C, Lang I. Evaluation of the CT imaging findings in patients newly diagnosed with chronic thromboembolic pulmonary hypertension. PLoS One 2018;13:e0201468
  18. Zhai Z, Ota H, Staring M, Stolk J, Sugimura K, Takase K, et al. Treatment effect of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension quantified by automatic comparative imaging in computed tomography pulmonary angiography. Invest Radiol 2018;53:286-292
  19. Kim NH, Delcroix M, Jenkins DP, Channick R, Dartevelle P, Jansa P, et al. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol 2013;62(25 Suppl):D92-D99
  20. Nishiyama KH, Saboo SS, Tanabe Y, Jasinowodolinski D, Landay MJ, Kay FU. Chronic pulmonary embolism: diagnosis. Cardiovasc Diagn Ther 2018;8:253-271
  21. Hong YJ, Shim J, Lee SM, Im DJ, Hur J. Dual-energy CT for pulmonary embolism: current and evolving clinical applications. Korean J Radiol 2021;22:1555-1568
  22. Synn AJ, Li W, San Jose Estepar R, Zhang C, Washko GR, O'Connor GT, et al. Radiographic pulmonary vessel volume, lung function and airways disease in the Framingham Heart Study. Eur Respir J 2019;54:1900408
  23. Zou KH, Tuncali K, Silverman SG. Correlation and simple linear regression. Radiology 2003;227:617-622
  24. Giannitsi S, Bougiakli M, Bechlioulis A, Kotsia A, Michalis LK, Naka KK. 6-minute walking test: a useful tool in the management of heart failure patients. Ther Adv Cardiovasc Dis 2019;13:1753944719870084
  25. Synn AJ, Li W, San Jose Estepar R, Washko GR, O'Connor GT, Tsao CW, et al. Pulmonary vascular pruning on computed tomography and risk of death in the Framingham Heart Study. Am J Respir Crit Care Med 2021;203:251-254
  26. Koike H, Sueyoshi E, Sakamoto I, Uetani M, Nakata T, Maemura K. Quantification of lung perfusion blood volume (lung PBV) by dual-energy CT in patients with chronic thromboembolic pulmonary hypertension (CTEPH) before and after balloon pulmonary angioplasty (BPA): preliminary results. Eur J Radiol 2016;85:1607-1612
  27. Chemla D, Lau EMT, Papelier Y, Attal P, Herve P. Pulmonary vascular resistance and compliance relationship in pulmonary hypertension. Eur Respir J 2015;46:1178-1189
  28. Santos-Gomes J, Gandra I, Adao R, Perros F, Bras-Silva C. An overview of circulating pulmonary arterial hypertension biomarkers. Front Cardiovasc Med 2022;9:924873
  29. Rahaghi FN, Argemi G, Nardelli P, Dominguez-Fandos D, Arguis P, Peinado VI, et al. Pulmonary vascular density: comparison of findings on computed tomography imaging with histology. Eur Respir J 2019;54:1900370
  30. Remy-Jardin M, Duthoit L, Perez T, Felloni P, Faivre JB, Fry S, et al. Assessment of pulmonary arterial circulation 3 months after hospitalization for SARS-CoV-2 pneumonia: Dual-energy CT (DECT) angiographic study in 55 patients. EClinicalMedicine 2021;34:100778
  31. Fisher MR, Forfia PR, Chamera E, Housten-Harris T, Champion HC, Girgis RE, et al. Accuracy of doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 2009;179:615-621
  32. Augustine DX, Coates-Bradshaw LD, Willis J, Harkness A, Ring L, Grapsa J, et al. Echocardiographic assessment of pulmonary hypertension: a guideline protocol from the British Society of Echocardiography. Echo Res Pract 2018;5:G11-G24
  33. Diaz AA, Maselli DJ, Rahaghi F, Come CE, Yen A, Maclean ES, et al. Pulmonary vascular pruning in smokers with bronchiectasis. ERJ Open Res 2018;4:00044-2018
  34. Yang T, Chen C, Chen Z. The CT pulmonary vascular parameters and disease severity in COPD patients on acute exacerbation: a correlation analysis. BMC Pulm Med 2021;21:34
  35. Ash SY, Rahaghi FN, Come CE, Ross JC, Colon AG, Cardet-Guisasola JC, et al. Pruning of the pulmonary vasculature in asthma. The Severe Asthma Research Program (SARP) cohort. Am J Respir Crit Care Med 2018;198:39-50